Combination of anti-PD-1 therapy and stereotactic radiosurgery for a gastric cancer patient with brain metastasis: a case report

BMC Cancer. 2018 Feb 12;18(1):173. doi: 10.1186/s12885-017-3906-0.

Abstract

Background: Brain metastases from gastric cancer are difficult to treat and their prognosis is poor. Despite various possible treatments, the survival rate of such patients is still unsatisfactory; therefore, new treatment modalities or combinations of therapies need to be explored.

Case presentation: We herein discuss a case of a 38-year-old man initially diagnosed with a gastric cancer brain metastasis. At first, only stereotactic radiosurgery (SRS) was performed, but it was not effective. After the brain and systemic metastases progressed, SRS and anti-PD-1 therapy were administered in combination, and the brain and intra-abdominal metastatic lesions responded satisfactorily.

Conclusion: The combination of anti-PD-1 therapy and SRS could be effective against gastric cancer with brain metastases.

Keywords: Anti-PD-1 therapy; Brain metastasis; Gastric cancer; Stereotactic radiosurgery.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Antineoplastic Agents, Immunological / administration & dosage
  • Antineoplastic Agents, Immunological / adverse effects
  • Antineoplastic Agents, Immunological / therapeutic use*
  • B7-H1 Antigen / antagonists & inhibitors
  • Biopsy
  • Brain Neoplasms / diagnosis
  • Brain Neoplasms / secondary*
  • Brain Neoplasms / therapy*
  • Combined Modality Therapy
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Molecular Targeted Therapy*
  • Radiosurgery* / adverse effects
  • Radiosurgery* / methods
  • Stomach Neoplasms / pathology*
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Immunological
  • B7-H1 Antigen
  • CD274 protein, human